ThetaPal ThetaPal

Manufacturing / Pharmaceutical Preparations

Aurinia Pharmaceuticals Inc.

AUPH

$16.74

+$0.42 (+2.59%)

Price as of Oct 9, 2026 19:56 UTC

2.2 B

Market Cap (Mid Cap)

10%

IV Rank

46.1%

Implied Volatility

Oct 29

Next Earnings

Technical Signals as of Oct 7
Mixed
4 of 7

Trend

  • Above 20-day average $16.18
  • Above 50-day average $16.12
  • Above 200-day average $15.38 · +4.1%
  • Moving averages stacked 20 > 50 > 200

Momentum

  • Golden cross (50/200) —
  • Momentum cross (20/50) 32d ago

Volume

  • Below-average volume 0.8x avg

Price & Trend

Daily candles with EMA 20, SMA 50. Drag to zoom.

Options Activity & Greeks

Implied volatility, flow, and dealer positioning from the options market.

Put/Call Ratio

0.18

Bullish skew

Implied Volatility

46.1%

0% percentile

IV vs Realized

Options rich

30d HV 34.7%

Options Heat Map

Delta-risk grid for AUPH options across strikes and expirations. Hover any cell for full Greeks.

Loading option chain data...

Insider Trades

14 buys 3 sells
Date Insider Title Type Shares Value Since Trade
Sep 10, 2026 Robertson Stephen P. Sell 11,939 $190,427 +1.7%
Aug 21, 2026 Robertson Stephen P. Sell 20,975 $355,946 -4.4%
Jun 04, 2026 Goetz Kathleen Grant 23,931 $0 -0.9%
Jun 04, 2026 Bailey Jeffrey Allen Grant 23,931 $0 -0.9%
Jun 04, 2026 Nova Tina Susan Grant 23,931 $0 -0.9%
Jun 04, 2026 Johnson Craig A Grant 23,931 $0 -0.9%
Jun 04, 2026 Nova Tina Susan Other 23,931 $0 -0.9%
Jun 04, 2026 Goetz Kathleen Other 23,931 $0 -0.9%
Jun 04, 2026 Bailey Jeffrey Allen Other 23,931 $0 -0.9%
Jun 04, 2026 Johnson Craig A Other 23,931 $0 -0.9%

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Jul 30, 2026 Q2 2026 $0.24
Jul 29, 2026 Q2 2026 $0.24
Mar 31, 2026 Q1 2026 $0.20 $0.25 +23.8% Beat
Dec 31, 2025 Q4 2025 $0.22 $0.26 +17.6% Beat
Sep 30, 2025 Q3 2025 $0.16 $0.23 +40.9% Beat
Jun 30, 2025 Q2 2025 $0.15 $0.16 +7.0% Beat
Mar 31, 2025 Q1 2025 $0.10 $0.16 +56.9% Beat

Track AUPH with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for AUPH and your entire portfolio.